Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study

BACKGROUND: Nucleotide analogues (NTs) monotherapy may have a more significant effect on reducing hepatitis B surface antigen (HBsAg) than nucleoside analogues (NSs) due to their immunomodulatory function. However, this superiority remains unknown when combined with PEGylated interferon α (PegIFNα)....

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yiran, Zhu, Haoxiang, Guo, Yifei, Ma, Zhenxuan, Qi, Xun, Yang, Feifei, Mao, Richeng, Zhang, Jiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750779/
https://www.ncbi.nlm.nih.gov/pubmed/36531834
http://dx.doi.org/10.1155/2022/4325352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750779/
https://www.ncbi.nlm.nih.gov/pubmed/36531834
http://dx.doi.org/10.1155/2022/4325352

Ejemplares similares